Susquehanna International Group’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
34,576
-4,630
| -12% | -$24.5K | ﹤0.01% | 5605 |
|
|
2025
Q1 | $319K | Buy |
39,206
+23,742
| +154% | +$193K | ﹤0.01% | 4948 |
|
|
2024
Q4 | $198K | Buy |
+15,464
| New | +$198K | ﹤0.01% | 5315 |
|
|
2024
Q3 | – | Sell |
-11,627
| Closed | -$92.1K | – | 6372 |
|
|
2024
Q2 | $92.1K | Sell |
11,627
-9,042
| -44% | -$71.6K | ﹤0.01% | 5118 |
|
|
2024
Q1 | $331K | Sell |
20,669
-23,416
| -53% | -$375K | ﹤0.01% | 4054 |
|
|
2023
Q4 | $605K | Sell |
44,085
-12,504
| -22% | -$172K | ﹤0.01% | 3575 |
|
|
2023
Q3 | $827K | Sell |
56,589
-23,223
| -29% | -$339K | ﹤0.01% | 2804 |
|
|
2023
Q2 | $1.36M | Sell |
79,812
-150,265
| -65% | -$2.56M | ﹤0.01% | 2336 |
|
|
2023
Q1 | $3.21M | Buy |
230,077
+154,468
| +204% | +$2.16M | ﹤0.01% | 1450 |
|
|
2022
Q4 | $499K | Buy |
+75,609
| New | +$499K | ﹤0.01% | 3227 |
|
|
2022
Q3 | – | Sell |
-74,526
| Closed | -$354K | – | 6758 |
|
|
2022
Q2 | $354K | Buy |
74,526
+25,232
| +51% | +$120K | ﹤0.01% | 3776 |
|
|
2022
Q1 | $418K | Buy |
49,294
+34,270
| +228% | +$291K | ﹤0.01% | 3927 |
|
|
2021
Q4 | $180K | Sell |
15,024
-13,110
| -47% | -$157K | ﹤0.01% | 5018 |
|
|
2021
Q3 | $499K | Buy |
28,134
+9,316
| +50% | +$165K | ﹤0.01% | 3716 |
|
|
2021
Q2 | $386K | Sell |
18,818
-101,403
| -84% | -$2.08M | ﹤0.01% | 4189 |
|
|
2021
Q1 | $2.38M | Buy |
120,221
+96,555
| +408% | +$1.91M | ﹤0.01% | 1909 |
|
|
2020
Q4 | $440K | Buy |
23,666
+12,259
| +107% | +$228K | ﹤0.01% | 3537 |
|
|
2020
Q3 | $287K | Buy |
11,407
+3,971
| +53% | +$99.9K | ﹤0.01% | 3574 |
|
|
2020
Q2 | $227K | Buy |
+7,436
| New | +$227K | ﹤0.01% | 3603 |
|